Validation and Concordance Analysis of a New Lateral Flow Assay for Detection of <i>Histoplasma</i> Antigen in Urine

Histoplasmosis is a major cause of mortality in people living with HIV (PLHIV). Rapid methods to diagnose <i>Histoplasma capsulatum</i> disease could dramatically decrease the time to initiate treatment, resulting in reduced mortality. The aim of this study was to validate a MiraVista<...

Full description

Bibliographic Details
Main Authors: Diego H. Cáceres, Beatriz L. Gómez, Ángela M. Tobón, Melissa Minderman, Nicole Bridges, Tom Chiller, Mark D. Lindsley
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Journal of Fungi
Subjects:
Online Access:https://www.mdpi.com/2309-608X/7/10/799
_version_ 1797514202691141632
author Diego H. Cáceres
Beatriz L. Gómez
Ángela M. Tobón
Melissa Minderman
Nicole Bridges
Tom Chiller
Mark D. Lindsley
author_facet Diego H. Cáceres
Beatriz L. Gómez
Ángela M. Tobón
Melissa Minderman
Nicole Bridges
Tom Chiller
Mark D. Lindsley
author_sort Diego H. Cáceres
collection DOAJ
description Histoplasmosis is a major cause of mortality in people living with HIV (PLHIV). Rapid methods to diagnose <i>Histoplasma capsulatum</i> disease could dramatically decrease the time to initiate treatment, resulting in reduced mortality. The aim of this study was to validate a MiraVista<sup>®</sup> Diagnostics (MVD) <i>Histoplasma</i> urine antigen lateral flow assay (MVD LFA) for the detection of <i>H. capsulatum</i> antigen (Ag) in urine and compare this LFA against the MVista<sup>®</sup> <i>Histoplasma</i> Ag quantitative enzyme immunoassays (MVD EIA). We assessed the MVD LFA using a standardized reference panel of urine specimens from Colombia. We tested 100 urine specimens, 26 from PLHIV diagnosed with histoplasmosis, 42 from PLHIV with other infectious diseases, and 32 from non-HIV infected persons without histoplasmosis. Sensitivity and specificity of the MVD LFA was 96%, compared with 96% sensitivity and 77% specificity of the MVD EIA. Concordance analysis between MVD LFA and the MVD EIA displayed an 84% agreement, and a Kappa of 0.656. The MVD LFA evaluated in this study has several advantages, including a turnaround time for results of approximately 40 min, no need for complex laboratory infrastructure or highly trained laboratory personnel, use of urine specimens, and ease of performing.
first_indexed 2024-03-10T06:28:17Z
format Article
id doaj.art-c9fa2ab0c92542e3992057cd2b0f7d4c
institution Directory Open Access Journal
issn 2309-608X
language English
last_indexed 2024-03-10T06:28:17Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Journal of Fungi
spelling doaj.art-c9fa2ab0c92542e3992057cd2b0f7d4c2023-11-22T18:46:38ZengMDPI AGJournal of Fungi2309-608X2021-09-0171079910.3390/jof7100799Validation and Concordance Analysis of a New Lateral Flow Assay for Detection of <i>Histoplasma</i> Antigen in UrineDiego H. Cáceres0Beatriz L. Gómez1Ángela M. Tobón2Melissa Minderman3Nicole Bridges4Tom Chiller5Mark D. Lindsley6Centers for Disease Control and Prevention CDC, Atlanta, GA 30329, USAStudies in Translational Microbiology and Emerging Diseases (MICROS Research Group), School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, ColombiaHospital La Maria, Medellín 050040, ColombiaMiraVista Diagnostics, Indianapolis, IN 46241, USAMiraVista Diagnostics, Indianapolis, IN 46241, USACenters for Disease Control and Prevention CDC, Atlanta, GA 30329, USACenters for Disease Control and Prevention CDC, Atlanta, GA 30329, USAHistoplasmosis is a major cause of mortality in people living with HIV (PLHIV). Rapid methods to diagnose <i>Histoplasma capsulatum</i> disease could dramatically decrease the time to initiate treatment, resulting in reduced mortality. The aim of this study was to validate a MiraVista<sup>®</sup> Diagnostics (MVD) <i>Histoplasma</i> urine antigen lateral flow assay (MVD LFA) for the detection of <i>H. capsulatum</i> antigen (Ag) in urine and compare this LFA against the MVista<sup>®</sup> <i>Histoplasma</i> Ag quantitative enzyme immunoassays (MVD EIA). We assessed the MVD LFA using a standardized reference panel of urine specimens from Colombia. We tested 100 urine specimens, 26 from PLHIV diagnosed with histoplasmosis, 42 from PLHIV with other infectious diseases, and 32 from non-HIV infected persons without histoplasmosis. Sensitivity and specificity of the MVD LFA was 96%, compared with 96% sensitivity and 77% specificity of the MVD EIA. Concordance analysis between MVD LFA and the MVD EIA displayed an 84% agreement, and a Kappa of 0.656. The MVD LFA evaluated in this study has several advantages, including a turnaround time for results of approximately 40 min, no need for complex laboratory infrastructure or highly trained laboratory personnel, use of urine specimens, and ease of performing.https://www.mdpi.com/2309-608X/7/10/799histoplasmosis<i>Histoplasma</i>antigenHIVAIDS
spellingShingle Diego H. Cáceres
Beatriz L. Gómez
Ángela M. Tobón
Melissa Minderman
Nicole Bridges
Tom Chiller
Mark D. Lindsley
Validation and Concordance Analysis of a New Lateral Flow Assay for Detection of <i>Histoplasma</i> Antigen in Urine
Journal of Fungi
histoplasmosis
<i>Histoplasma</i>
antigen
HIV
AIDS
title Validation and Concordance Analysis of a New Lateral Flow Assay for Detection of <i>Histoplasma</i> Antigen in Urine
title_full Validation and Concordance Analysis of a New Lateral Flow Assay for Detection of <i>Histoplasma</i> Antigen in Urine
title_fullStr Validation and Concordance Analysis of a New Lateral Flow Assay for Detection of <i>Histoplasma</i> Antigen in Urine
title_full_unstemmed Validation and Concordance Analysis of a New Lateral Flow Assay for Detection of <i>Histoplasma</i> Antigen in Urine
title_short Validation and Concordance Analysis of a New Lateral Flow Assay for Detection of <i>Histoplasma</i> Antigen in Urine
title_sort validation and concordance analysis of a new lateral flow assay for detection of i histoplasma i antigen in urine
topic histoplasmosis
<i>Histoplasma</i>
antigen
HIV
AIDS
url https://www.mdpi.com/2309-608X/7/10/799
work_keys_str_mv AT diegohcaceres validationandconcordanceanalysisofanewlateralflowassayfordetectionofihistoplasmaiantigeninurine
AT beatrizlgomez validationandconcordanceanalysisofanewlateralflowassayfordetectionofihistoplasmaiantigeninurine
AT angelamtobon validationandconcordanceanalysisofanewlateralflowassayfordetectionofihistoplasmaiantigeninurine
AT melissaminderman validationandconcordanceanalysisofanewlateralflowassayfordetectionofihistoplasmaiantigeninurine
AT nicolebridges validationandconcordanceanalysisofanewlateralflowassayfordetectionofihistoplasmaiantigeninurine
AT tomchiller validationandconcordanceanalysisofanewlateralflowassayfordetectionofihistoplasmaiantigeninurine
AT markdlindsley validationandconcordanceanalysisofanewlateralflowassayfordetectionofihistoplasmaiantigeninurine